Juli Schlichtiger

721 total citations
9 papers, 577 citations indexed

About

Juli Schlichtiger is a scholar working on Psychiatry and Mental health, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Juli Schlichtiger has authored 9 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 6 papers in Oncology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Juli Schlichtiger's work include Epilepsy research and treatment (6 papers), Drug Transport and Resistance Mechanisms (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Juli Schlichtiger is often cited by papers focused on Epilepsy research and treatment (6 papers), Drug Transport and Resistance Mechanisms (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Juli Schlichtiger collaborates with scholars based in Germany, United States and Netherlands. Juli Schlichtiger's co-authors include Anton Pekcec, Heidrun Potschka, Anika M. S. Hartz, Emma L. B. Soldner, Erwin A. van Vliet, Jan A. Gorter, Jonna Soerensen, Björn Bauer, Ralf G. Rempe and Richard J. Kryscio and has published in prestigious journals such as Journal of Neuroscience, The FASEB Journal and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Juli Schlichtiger

9 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juli Schlichtiger Germany	8	234	230	174	172	138	9	577
Linda Holtman Netherlands	8	147 0.6×	283 1.2×	160 0.9×	291 1.7×	172 1.2×	9	621
Alexandra M. Gastens Germany	7	295 1.3×	375 1.6×	363 2.1×	255 1.5×	127 0.9×	7	700
Kerstin Römermann Germany	21	463 2.0×	378 1.6×	427 2.5×	331 1.9×	295 2.1×	30	1.1k
Elena Girardi Argentina	13	216 0.9×	274 1.2×	242 1.4×	232 1.3×	164 1.2×	31	590
Emma L. B. Soldner United States	6	102 0.4×	75 0.3×	96 0.6×	75 0.4×	103 0.7×	10	479
Bjoern Bauer United States	10	194 0.8×	49 0.2×	93 0.5×	58 0.3×	181 1.3×	16	532
Aimee Jones United States	6	168 0.7×	47 0.2×	69 0.4×	61 0.4×	195 1.4×	9	582
Maike Glien Germany	9	78 0.3×	355 1.5×	194 1.1×	404 2.3×	238 1.7×	10	660
Daniela Buonvicino Italy	13	65 0.3×	73 0.3×	27 0.2×	81 0.5×	234 1.7×	36	474
Anchen Guo China	12	61 0.3×	47 0.2×	34 0.2×	84 0.5×	218 1.6×	22	485

Countries citing papers authored by Juli Schlichtiger

Since Specialization

Citations

This map shows the geographic impact of Juli Schlichtiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juli Schlichtiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juli Schlichtiger more than expected).

Fields of papers citing papers by Juli Schlichtiger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juli Schlichtiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juli Schlichtiger. The network helps show where Juli Schlichtiger may publish in the future.

Co-authorship network of co-authors of Juli Schlichtiger

This figure shows the co-authorship network connecting the top 25 collaborators of Juli Schlichtiger. A scholar is included among the top collaborators of Juli Schlichtiger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juli Schlichtiger. Juli Schlichtiger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Hartz, Anika M. S., Ralf G. Rempe, Emma L. B. Soldner, et al.. (2019). Cytosolic phospholipase A2 is a key regulator of blood‐brain barrier function in epilepsy. The FASEB Journal. 33(12). 14281–14295. 24 indexed citations

Rempe, Ralf G., Anika M. S. Hartz, Emma L. B. Soldner, et al.. (2018). Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy. Journal of Neuroscience. 38(18). 4301–4315. 121 indexed citations

Hartz, Anika M. S., Anton Pekcec, Emma L. B. Soldner, et al.. (2017). P-gp Protein Expression and Transport Activity in Rodent Seizure Models and Human Epilepsy. Molecular Pharmaceutics. 14(4). 999–1011. 63 indexed citations

Hartenbach, Markus, Andreas Delker, Sabrina Hartenbach, et al.. (2014). Dose-Dependent Uptake of 3′-deoxy-3′-[18 F]Fluorothymidine by the Bowel after Total-Body Irradiation. Molecular Imaging and Biology. 16(6). 846–853. 1 indexed citations

Rominger, Axel, Matthias Brendel, Steffen Burgold, et al.. (2013). Longitudinal Assessment of Cerebral β-Amyloid Deposition in Mice Overexpressing Swedish Mutant β-Amyloid Precursor Protein Using ¹⁸F-Florbetaben PET. Journal of Nuclear Medicine. 54(7). 1127–1134. 60 indexed citations

Fougère, Christian la, Guoming Xiong, Juli Schlichtiger, et al.. (2010). Imaging of P‐glycoprotein–mediated pharmacoresistance in the hippocampus: Proof‐of‐concept in a chronic rat model of temporal lobe epilepsy. Epilepsia. 51(9). 1780–1790. 37 indexed citations

Schlichtiger, Juli, et al.. (2010). Celecoxib treatment restores pharmacosensitivity in a rat model of pharmacoresistant epilepsy. British Journal of Pharmacology. 160(5). 1062–1071. 73 indexed citations

Vliet, Erwin A. van, Anton Pekcec, Juli Schlichtiger, et al.. (2009). COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats. Neuropharmacology. 58(2). 404–412. 116 indexed citations

Pekcec, Anton, Juli Schlichtiger, Jonna Soerensen, et al.. (2009). Targeting Prostaglandin E2 EP1 Receptors Prevents Seizure-Associated P-glycoprotein Up-Regulation. Journal of Pharmacology and Experimental Therapeutics. 330(3). 939–947. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact